Meropenem and Sulbactam Injection is a broad-spectrum beta-lactam antibiotic combination used in the management of severe and complicated bacterial infections, particularly those caused by multi-drug resistant organisms.
Meropenem provides powerful bactericidal activity against Gram-positive, Gram-negative, and anaerobic pathogens, while sulbactam enhances efficacy by inhibiting beta-lactamase enzymes, protecting the antibiotic from degradation.
This combination is commonly prescribed in sepsis, pneumonia, intra-abdominal infections, urinary tract infections, skin and soft tissue infections, and other critical hospital-based conditions requiring aggressive antimicrobial therapy.
With increasing resistance patterns and rising demand for advanced injectable antibiotics in hospitals, this formulation supports strong market acceptance, repeat institutional demand, and consistent growth by meeting the needs of critical care and emergency infection management.
Common side effects may include injection site pain, nausea, vomiting, diarrhea, headache, or rash. Rarely, hypersensitivity reactions, altered liver enzymes, or hematological changes may occur.
Merotyle S 1.5 Injection is indicated for the treatment of severe and complicated bacterial infections including respiratory tract infections, intra-abdominal infections, urinary tract infections, skin and soft tissue infections, septicemia, and hospital-acquired infections caused by susceptible organisms, as advised by a physician.
For intravenous use only under strict medical supervision. Dosage and duration should be determined by the physician based on the severity of infection and patient condition. Use with caution in patients with renal impairment or a history of beta-lactam allergy.
Store below 25°C in a cool, dry place. Protect from light. Reconstituted solution should be used immediately or as directed by a healthcare professional. Keep out of reach of children.